-10.3 (-1.92%)
-10.15 (-1.89%) 4.46 pm | 28 May 2012 | Source: Reuters
Ranbaxy Laboratories has received US approval for acne treatment drug Absorica and expects a US launch in the fourth quarter of this year....
9.01 am | 26 Apr 2012 | Source: PTI
Ranbaxy Laboratories said the company has no plans to delist from Indian bourses and it will remain a listed company....
10.07 pm | 25 Apr 2012 | Source: CNBC-TV18
Ranbaxy managing director and chief executive Arun Sawhney told CNBC-TV18 that the pharmaceutical company would end fiscal 2012 with better sales and ...
4.26 pm | 25 Apr 2012 | Source: Reuters
Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduc...